Risk of movement disorders is low in pediatric patients treated with risperidone

被引：0
|
作者：
Bossie, CA [1 ]
Pandina, G [1 ]
Zhu, Y [1 ]
Gharabawi, G [1 ]
机构：
[1] Janssen Pharmaceut LP, Titusville, NJ USA
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2004年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：521 / 522
页数：2
相关论文
共 50 条
  • [21] Movement disorders in mitochondrial disease: Radio clinical correlation in pediatric patients
    Zouari, R.
    Naifar, M.
    Kamoun, F.
    Ben Nsir, S.
    Ben Jemaa, R.
    Bouchaala, W.
    Ayadi, F.
    Triki, C.
    MOVEMENT DISORDERS, 2018, 33 : S214 - S214
  • [22] Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease: Need More Evidence
    Hu, Fei-Hong
    Chen, Hong-Lin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (06): : 1101 - 1102
  • [23] Movement Disorders in Genetic Pediatric Ataxias
    Gana, Simone
    Valente, Enza Maria
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (04): : 383 - 393
  • [24] Pediatric Movement Disorders and Neuromodulation: An Overview
    Kulkarni, Shilpa D.
    Kothari, Sonam R.
    NEUROLOGY INDIA, 2020, 68 : 206 - 212
  • [25] Influence of Kidney Function on Serum Risperidone Concentrations in Patients Treated With Risperidone
    Gruender, Philipp
    Augustin, Marc
    Paulzen, Michael
    Gruender, Gerhard
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (06) : E1 - E5
  • [26] A survey of movement disorders in a large sample of patients treated with antipsychotic medication
    Balint, B.
    Killaspy, H.
    Barnes, T. R. E.
    Freemantle, N.
    Joyce, E.
    Martino, D.
    Bhatia, K. P.
    MOVEMENT DISORDERS, 2016, 31 : S294 - S294
  • [27] Risk of tuberculosis in pediatric patients treated with biological agents
    Asfuroglu, Pelin
    Gursoy, Tugba Ramasli
    Onay, Zeynep Reyhan
    Eyuboglu, Tugba Sismanlar
    Yayla, Emine Nur Sunar
    Aslan, Ayse Tana
    Ezgu, Sevcan Azime Bakkaloglu
    Soylemezoglu, Husnu Oguz
    Buyan, Necla
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [28] Metabolic profile in children with disruptive behavior disorders treated with risperidone
    Reyes, M
    Pandina, G
    Trinh, B
    Augustyns, I
    Moreau-Mallet, V
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S506 - S507
  • [29] Risperidone-induced hepatotoxicity in pediatric patients
    Kumra, S
    Herion, D
    Jacobsen, LK
    Briguglia, C
    Grothe, D
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 540 - 540
  • [30] Risperidone in the treatment of elderly patients with psychotic disorders
    Madhusoodanan, S
    Brecher, M
    Brenner, R
    Kasckow, J
    Kunik, M
    Negrón, AE
    Pomara, N
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 7 (02): : 132 - 138
12345